S
Suzanne Oparil
Researcher at University of Alabama at Birmingham
Publications - 941
Citations - 122414
Suzanne Oparil is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Blood pressure & Angiotensin II. The author has an hindex of 106, co-authored 885 publications receiving 113983 citations. Previous affiliations of Suzanne Oparil include Michigan State University & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Association between chronic kidney disease and cancer mortality: A report from the ALLHAT.
Dhruti P. Chen,Barry R. Davis,Lara M. Simpson,William C. Cushman,Jeffrey A. Cutler,Mirela Dobre,Charles E. Ford,Gail T. Louis,Paul Muntner,Suzanne Oparil,Linda B. Piller,Sara L. Pressel,Mark J. Sarnak,Paul K. Whelton,Jackson T. Wright,Mahboob Rahman +15 more
TL;DR: In a large cohort of hypertensive patients, GFR < 45 mL/min/1.73 m2 was associated with a higher risk of cancer-related mortality, consistent across subgroups defined by race, gender, and diabetes.
Journal ArticleDOI
Masked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion
Mohammed Siddiqui,Eric Judd,Bin Zhang,Bin Zhang,Tanja Dudenbostel,Robert M. Carey,Suzanne Oparil,David A. Calhoun +7 more
TL;DR: This study suggests that patients with MUCH likely have higher out-of-clinic sympathetic nervous system tone increases aldosterone secretion mediated by increased renin release that may contribute to their higher out of-Clinic BP.
Journal ArticleDOI
Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy
Suzanne Oparil,Thomas D. Giles,Elizabeth Ofili,Bertram Pitt,Yodit Seifu,Robert Hilkert,Rita Samuel,James R. Sowers +7 more
TL;DR: Starting treatment with an intensive dose of amlodipine/valsartan provides significantly greater BP lowering versus moderate treatment in hypertensive patients unresponsive to ARB monotherapy.
Journal ArticleDOI
Secondary prevention of coronary heart disease in women: a call to action.
Andrew P. Miller,Suzanne Oparil +1 more
TL;DR: Data is analyzed from the HERS study to identify risk factors for myocardial infarction and CHD death and describe use of secondary prevention strategies by the participants and to identify Elevated lipoprotein(a) levels emerged as a novel risk factor only in the placebo group.
Journal ArticleDOI
Treating multiple-risk hypertensive populations.
TL;DR: Lowering BP to levels well below the traditional goal of 140/90 mm Hg is needed to slow the progression of renal dysfunction and prevent renal failure in hypertensive patients with renal disease, whether related to diabetes or to another etiology.